171 related articles for article (PubMed ID: 2406852)
1. Effect of oral bismuth subsalicylate on Campylobacter pylori and on healing and relapse rate of peptic ulcer.
Eberhardt R; Kasper G
Rev Infect Dis; 1990; 12 Suppl 1():S115-9. PubMed ID: 2406852
[TBL] [Abstract][Full Text] [Related]
2. [Effect of bismuth subsalicylate versus cimetidine on Campylobacter pylori, ulcer healing and rate of recurrence].
Eberhardt R; Kasper G; Dettmer A; Höchter W; Hagena D
Med Klin (Munich); 1988 May; 83(12):402-5. PubMed ID: 3043160
[No Abstract] [Full Text] [Related]
3. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
Rösch W
Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
[TBL] [Abstract][Full Text] [Related]
4. Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial.
Humphreys H; Bourke S; Dooley C; McKenna D; Power B; Keane CT; Sweeney EC; O'Moráin C
Gut; 1988 Mar; 29(3):279-83. PubMed ID: 3356357
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin.
Drumm B; Sherman P; Chiasson D; Karmali M; Cutz E
J Pediatr; 1988 Nov; 113(5):908-12. PubMed ID: 3183851
[TBL] [Abstract][Full Text] [Related]
6. Ulcer relapse rates following initial treatment with bismuth subnitrate as compared with cimetidine respectively.
Topfmeier P; Eberhardt R; Mateblowski M; Kuhn D
Int J Clin Pharmacol Ther Toxicol; 1991 Nov; 29(11):437-40. PubMed ID: 1800390
[TBL] [Abstract][Full Text] [Related]
7. Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori.
McNulty CA
Rev Infect Dis; 1990; 12 Suppl 1():S94-8. PubMed ID: 2406863
[TBL] [Abstract][Full Text] [Related]
8. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.
Marshall BJ; Goodwin CS; Warren JR; Murray R; Blincow ED; Blackbourn SJ; Phillips M; Waters TE; Sanderson CR
Lancet; 1988 Dec 24-31; 2(8626-8627):1437-42. PubMed ID: 2904568
[TBL] [Abstract][Full Text] [Related]
9. [Bismuth subsalicylate treatment in chronic Campylobacter pylori-associated erosive gastritis].
Malfertheiner P; Stanescu A; Baczako K; Vanek E; Bode G; Ditschuneit H
Dtsch Med Wochenschr; 1988 Jun; 113(23):923-9. PubMed ID: 3378501
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with Campylobacter pylori in western Kentucky.
Kraus JW; Morello PJ
J Ky Med Assoc; 1989 Sep; 87(9):448-50. PubMed ID: 2794757
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiology and therapy of Campylobacter pylori infection].
Wagner S; Freise J; Bär W; Fritsch S; Schmidt FW
Dtsch Med Wochenschr; 1989 Mar; 114(11):407-13. PubMed ID: 2707124
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
Graham DY; Hepps KS; Ramirez FC; Lew GM; Saeed ZA
Scand J Gastroenterol; 1993 Nov; 28(11):939-42. PubMed ID: 8284627
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis.
Marshall BJ; Armstrong JA; Francis GJ; Nokes NT; Wee SH
Digestion; 1987; 37 Suppl 2():16-30. PubMed ID: 3622946
[TBL] [Abstract][Full Text] [Related]
14. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
Wagstaff AJ; Benfield P; Monk JP
Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
[TBL] [Abstract][Full Text] [Related]
15. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Graham DY; Lew GM; Klein PD; Evans DG; Evans DJ; Saeed ZA; Malaty HM
Ann Intern Med; 1992 May; 116(9):705-8. PubMed ID: 1558340
[TBL] [Abstract][Full Text] [Related]
16. Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: role of Helicobacter pylori.
Wagner S; Gebel M; Haruma K; Bär W; Lange P; Freise J; Gladziwa U; Schmidt FW
Gut; 1992 Feb; 33(2):179-83. PubMed ID: 1347278
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer.
Vantrappen G; Schuurmans P; Rutgeerts P; Janssens J
Scand J Gastroenterol Suppl; 1982; 80():23-30. PubMed ID: 6761849
[TBL] [Abstract][Full Text] [Related]
18. Bismuth: effects on gastritis and peptic ulcer.
Rokkas T; Sladen GE
Scand J Gastroenterol Suppl; 1988; 142():82-6. PubMed ID: 3047853
[TBL] [Abstract][Full Text] [Related]
19. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.
Goodwin CS; Marshall BJ; Blincow ED; Wilson DH; Blackbourn S; Phillips M
J Clin Pathol; 1988 Feb; 41(2):207-10. PubMed ID: 3280609
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
Morris A; Brown P; Ali MR; Lane M; Palmer R
N Z Med J; 1988 Oct; 101(856 Pt 1):651-4. PubMed ID: 3054641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
